Evotec Partners with Pfizer for Drug Discovery Advancement Across France
Shots:
- Evotec has signed a multi-year master research collaboration and option & license agreement with Pfizer to advance drug discovery addressing metabolic and infectious diseases
- As per the terms of the agreement, Pfizer will fund the development of programs while Evotec will obtain milestones and royalties on their successful development
- The research activities will be conducted across Campus Curie in Toulouse, France which is equipped with high throughput screening, in vitro and in vivo biology, proteomics & metabolomics
Ref: Evotec | Image: Evotec
Related News:- Bayer and Evotec Join Forces to Develop Treatment for Cardiovascular Diseases
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
